Gilead Claims ‘Positive Data’ to Come From N.I.H. Trial of Remdesivir


By BY GINA KOLATA via NYT Health https://ift.tt/2yYBdr9 Neither the company nor the institutes discussed the data. Previous results for the potential coronavirus treatment have been inconclusive. New York Times

Comments